Rapid intrahepatic and peripheral blood HCV RNA decline and HCV-specific immune response increase during IFN-free DAA therapy in HCV treatment-naive patients

被引:0
|
作者
MacParland, Sonya A. [1 ,2 ]
Cherepanov, Vera [1 ,2 ]
Vijgen, Leen [4 ]
Gamil, Mohamed [4 ]
Beumont, Maria [4 ]
Yoon, Sharon [1 ]
Rahman, A. K. M. Nur-Ur [1 ]
Aquino, Analiza [5 ]
Capraru, Camelia [2 ]
Brahmania, Mayur [1 ]
Ostrowski, Mario [1 ]
Wong, David K. [2 ]
Janssen, Harry L. [2 ]
Sulkowski, Mark S. [3 ]
Feid, Jordan J. [1 ,2 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] McLaughlin Rotman Ctr Global Hlth, Toronto Ctr Liver Dis, Toronto, ON, Canada
[3] Johns Hopkins Univ, Sch Med, Bethesda, MD USA
[4] Janssen Infect Dis BVBA, Beerse, Belgium
[5] Mt Sinai Hosp, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1465
引用
收藏
页码:732A / 732A
页数:1
相关论文
共 50 条
  • [41] IMPACT OF ONCE-DAILY PROLONGED-RELEASE TACROLIMUS ON HCV-SPECIFIC IMMUNE RESPONSE OF PATIENTS UNDERWENT OLTx COMPARED TO TWICE A DAY TACROLIMUS TREATMENT
    Perrella, Alessandro
    Pisaniello, Donatella
    Cuomo, Oreste
    TRANSPLANT INTERNATIONAL, 2011, 24 : 252 - 252
  • [42] Impact of Once-Daily Prolonged-Release Tacrolimus on HCV-Specific Immune Response of Patients Underwent OLTx Compared to Twice a Day Tacrolimus Treatment
    Perrella, Alessandro
    D'Antonio, Anna
    Perrella, Oreste
    Cuomo, Oreste
    LIVER TRANSPLANTATION, 2011, 17 (06) : S264 - S264
  • [43] IMPACT OF ONCE-DAILY PROLONGED-RELEASE TACROLIMUS ON HCV-SPECIFIC IMMUNE RESPONSE OF PATIENTS UNDERWENT OLTx COMPARED TO TWICE A DAY TACROLIMUS TREATMENT
    Perrella, Alessandro
    Pisaniello, Donatella
    Santaniello, Walter
    Campanella, Luca
    Cuomo, Oreste
    TRANSPLANT INTERNATIONAL, 2011, 24 : 252 - 253
  • [44] Impact of Once-Daily Prolonged-Release Tacrolimus on HCV-Specific Immune Response of Patients Underwent OLTx Compared to Twice a Day Tacrolimus Treatment
    Perrella, A.
    Pisaniello, D.
    Marcos, A.
    Cuomo, O.
    TRANSPLANTATION, 2012, 94 (10) : 744 - 744
  • [45] Absence of HCV RNA from the peripheral blood mononuclear cells is a predictor of good response after treatment of Egyptian Chronic hepatitis C patients with sofosbuvir based therapy
    Mostafa, Hanan
    Zaghloul, Mariam
    Ragab, Dalia
    Ghazal, Abeer
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 379 - 379
  • [46] RAPID AND SUSTAINED ACHIEVEMENT OF UNDETECTABLE HCV RNA DURING TREATMENT WITH RITONAVIR-BOOSTED DANOPREVIR/PEG-IFNα-2A/RBV IN HCV GENOTYPE 1 OR 4 PATIENTS: DAUPHINE WEEK 12 INTERIM ANALYSIS
    Everson, G.
    Cooper, C.
    Hezode, C.
    Shiffman, M. L.
    Yoshida, E.
    Beltran-Jaramillo, T.
    Ferenci, P.
    Zeuzem, S.
    Brunda, M.
    Shulman, N.
    Navarro, M.
    Voulgari, A.
    Najera, I.
    Le Pogam, S.
    Yetzer, E. S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S466 - S466
  • [47] Telaprevir combination therapy in treatment-naive and -experienced patients co-infected with HCV/HIV (INSIGHT STUDY): sustained virologic response at 12 weeks final analysis
    Montes, Marisa L.
    Nelson, Mark
    Girard, Pierre-Marie
    Sasadeusz, Joe
    Horban, Andrzej
    Grinsztejn, Beatriz
    Zakharova, Natalia
    Rivero, Antonio
    Lathouwers, Erkki
    Janssen, Katrien
    Ouwerkerk-Mahadevan, Sivi
    Witek, James
    HEPATOLOGY, 2014, 60 : 678A - 678A
  • [48] Alisporivir plus Ribavirin achieves high rates of sustained HCV clearance (SVR24) as interferon (IFN)-free or IFN-add-on regimen in treatment-naive patients with HCV GT2 or GT3: Final results from VITAL-1 study
    Pawlotsky, Jean-Michel
    Sarin, Shiv K.
    Foster, Graham R.
    Peng, Cheng-Yuan
    Rasenack, Jens
    Flisiak, Robert
    Piratvisuth, Teerha
    Wedemeyer, Heiner
    Chuang, Wan-Long
    Zhang, Wei
    Naoumov, Nikolai V.
    HEPATOLOGY, 2012, 56 : 309A - 310A
  • [49] Comparison of whole peripheral blood and serum for the detection of hepatitis C virus (HCV) RNA in patients under combined high dose interferon (IFN) and ribavirin treatment.
    Watkins-Riedel, T
    Woegerbauer, MJ
    Schoenberger, B
    Kury, F
    Hofer, H
    Gschwantler, M
    Hofmann, H
    Steindl-Munda, PJ
    Mueller, C
    Jessner, W
    Ferenci, P
    HEPATOLOGY, 2000, 32 (04) : 547A - 547A
  • [50] Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells
    Coppola, Nicola
    De Pascalis, Stefania
    Pisaturo, Mariantonietta
    Paradiso, Laurenza
    Macera, Margherita
    Capoluongo, Nicolina
    Alessio, Loredana
    Stanzione, Maria
    Sagnelli, Caterina
    Minichini, Carmine
    Sagnelli, Evangelista
    JOURNAL OF CLINICAL VIROLOGY, 2013, 58 (04) : 748 - 750